NGX Bio is an online marketplace that connects researchers with DNA sequencing services, offering next-generation sequencing and bioinformatics in a CLIA/CLEP and CAP accredited environment. The platform addresses the need for reliable, high-quality sequencing solutions by providing fast turnaround times and expert scientific support tailored to diverse research projects.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Researchers often face challenges in accessing reliable and high-quality DNA sequencing services with fast turnaround times and expert scientific support. The need for sequencing solutions tailored to diverse research projects, operating in accredited environments, can also be a hurdle.
Solution
Admera Health provides research-grade Next-Generation Sequencing and bioinformatics services, connecting researchers with an online marketplace for DNA sequencing. Admera Health combines expert scientific support, advanced laboratory processes, stringent quality control measures, and proven quality project management to deliver superior service. Operating in a CLIA/CLEP and CAP accredited environment, Admera ensures projects are handled with exceptional care. The platform offers a range of services including genomics, transcriptomics, single-cell analysis, epigenomics, spatial transcriptomics, sequencing only, and bioinformatics.
Target Audience
The primary customers are researchers in preclinical development who require reliable, high-quality DNA sequencing and bioinformatics services.
Features
- Next-Generation Sequencing (NGS) services
- Bioinformatic services
- Genomics solutions
- Transcriptomics solutions
- Single-Cell analysis
- Epigenomics solutions
- Spatial Transcriptomics solutions
- Operation in a CLIA/CLEP and CAP accredited environment